Carboplatin and Oxaliplatin in Sequenced Combination With Bortezomib in Ovarian Tumour Models

Journal of Ovarian Research - United Kingdom
doi 10.1186/1757-2215-6-78
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Carboplatin in Combination With Epirubicin and Cyclophosphamide in Patients With Advanced Ovarian Cancer: A Phase II Study

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1995English

Rapamycin by Itself and Additively in Combination With Carboplatin Inhibits the Growth of Ovarian Cancer Cells

Gynecologic Oncology
GynecologyOncologyObstetrics
2009English

Brivanib in Combination With Notch3 Silencing Shows Potent Activity in Tumour Models

British Journal of Cancer
Cancer ResearchOncology
2019English

A Pilot Study of Carboplatin (JM8, CBDCA) and Chlorambucil in Combination for Advanced Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1988English

STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models

Oncotarget
Oncology
2018English

Hypomagnesemia and Survival in Patients With Ovarian Cancer Who Received Chemotherapy With Carboplatin

Oncologist
Cancer ResearchMedicineOncology
2019English

Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

IKKβ Inhibitor in Combination With Bortezomib Induces Cytotoxicity in Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2014English

A Phase I Trial of Dasatinib, an SRC-Family Kinase Inhibitor, in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy